New generation non-invasive prenatal test

During pregnancy, fetal DNA travels from the placenta to the mother’s blood stream and circulates along with her own DNA. VERACITY is a new generation non-invasive prenatal test that accurately measures the fetal cell-free DNA in the maternal blood to detect the presence of fetal aneuploidies. VERACITY has been validated for both single and twin pregnancies.

The doctor or lab collects a blood sample from the mother’s arm and sends it to our state-of-the-art laboratories for analysis. At the laboratory, cell-free DNA is isolated from the mother’s blood and analyzed using our proprietary, new generation analytic and bioinformatic technology. Results are provided to your doctor in a few working days.

VERACITY services are provided from our state-of-the-art laboratories that have been accredited by the College of American Pathologists.

Know your prenatal testing options

Options Accuracy Safety Time
First Trimester Screening Low
(80 – 95%)
No risk of miscarriage Can be done between 11 and 14 weeks
Invasive Prenatal Diagnosis Very High (>99%) 0.5% risk of miscarriage Can be done after 10 weeks (CVS)
or 15 weeks (amniocentesis)
New Generation Non-invasive Test
Very High (>99%)
No risk of miscarriage
Can be done as early as 10 weeks